Structural and mechanistic studies of self and non-self recognition by RIG-1

RIG-1自我和非自我识别的结构和机制研究

• 批准号: 9207521
• 负责人: Joseph Marcotrigiano
• 金额: $ 0.59万
• 依托单位: RUTGERS, THE STATE UNIV OF N.J.
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-15 至 2018-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9207521
• 关键词: ATP Hydrolysis; ATP phosphohydrolase; Address; Affect; Affinity; Anti-Inflammatory Agents; Anti-inflammatory; Antiviral Agents; Area; Autoimmune Process; Binding; Biochemical; Biological Assay; Caspase; Cells; Collection; Complement; Complex; Cytoplasm; Cytoplasmic Receptors; Dengue; Deuterium; Development; Disease; Disulfides; Double-Stranded RNA; Ducks; Ebola virus; Enzymatic Biochemistry; Failure; Fluorescence; Gene Silencing; Genes; Goals; Grant; Health; Hepatitis C; Human; Hydrogen; Immune; Immune response; Immune system; Infection; Influenza; Kinetics; Laboratories; Lead; Length; Measures; Methods; Modeling; Modification; Molecular; Molecular Conformation; Monitor; Movement; Natural Immunity; Outcome; Pathway interactions; Pattern; Pattern Recognition; Physiological; Play; Post-Translational Modification Site; Process; Property; Proteins; Publishing; RNA; RNA Binding; RNA Virus Infections; Reaction; Reagent; Reovirus; Research Project Grants; Resolution; Role; Series; Signal Transduction; Solvents; Structure; Systemic infection; Testing; Therapeutic; Thermodynamics; Tretinoin; Viral; Virus; Virus Diseases; West Nile virus; X-Ray Crystallography; analog; base; design; helicase; insight; microbial; mutant; pathogen; prevent; receptor; research study; respiratory; structural biology; therapeutic development; tripolyphosphate; viral RNA

DESCRIPTION (provided by applicant): The innate immune system is the first line of defense against microbial and viral infections. A failure to elicit the early innate immune response leads to systemic infections. A significant number of human viruses, including Influenza, Hepatitis C, Dengue, West Nile, Respiratory Syncytial, Reovirus, and Ebola are recognized by the innate immunity receptor RIG-I. The overall goal of this proposal is to understand how RIG-I (Retinoic Acid-inducible Gene-I), a cytoplasmic receptor discriminates normal, cellular from viral RNAs to stimulate a host response. A major goal of our collaborative research studies has been to understand the thermodynamic, kinetic, and structural mechanisms by which RIG-I recognizes atypical pathogen associated molecular pattern (PAMP) feature in RNAs. Our crystal structure of RIG-I bound to blunt-ended dsRNA and an ATP analog established a new paradigm for RIG-I activation. The goal of this proposal is to rigorously test the RIG-I activation model using carefully designed biochemical, kinetic, and structural studies. Our preliminary results demonstrate that RIG-I is regulated in multiple ways and RNA binding affinity is not the only criterion for PAMP selection. With a unique collection of purified protein, RNA reagents, we will employ complementary biochemical, biophysical, structural, and cell based approaches to 1) understand the basis of PAMP versus non-PAMP recognition of RNA by RIG-I; 2) characterize RIG-I ATPase activity and its role in RIG-I activation; and 3) understand the mechanism of RIG-I signaling. The outcomes are better understanding of self versus non-self recognition and RIG-I evasion mechanism, which can lead to the development of broad-spectrum antivirals, anti-inflammatory therapeutics and RNA-based gene silencing agents.

描述（由申请人提供）：先天免疫系统是抵抗微生物和病毒感染的第一道防线。未能引起早期先天免疫应答导致全身感染。大量的人类病毒，包括流感病毒、丙型肝炎病毒、登革热病毒、西尼罗河病毒、呼吸道合胞病毒、呼肠孤病毒和埃博拉病毒，被先天免疫受体RIG-I识别。本研究的总体目标是了解RIG-I（视黄酸诱导基因-I），一种细胞质受体如何区分正常的细胞RNA和病毒RNA，以刺激宿主反应。我们合作研究的一个主要目标是了解RIG-I识别RNA中非典型病原体相关分子模式（PAMP）特征的热力学，动力学和结构机制。我们的RIG-I的晶体结构结合到钝端dsRNA和ATP类似物建立了RIG-I激活的新范例。该提案的目标是使用精心设计的生化、动力学和结构研究来严格测试RIG-I激活模型。我们的初步研究结果表明，RIG-I的调节以多种方式和RNA结合亲和力不是唯一的标准PAMP选择。通过独特的纯化蛋白质、RNA试剂的收集，我们将采用互补的生物化学、生物物理学、结构和基于细胞的方法来1）理解RIG-I对RNA的PAMP与非PAMP识别的基础; 2）表征RIG-I ATP酶活性及其在RIG-I活化中的作用;和3）理解RIG-I信号传导的机制。结果是更好地理解自我与非自我识别和RIG-I逃避机制，这可以导致广谱抗病毒药物，抗炎治疗和基于RNA的基因沉默剂的发展。